MA54243A - Composé de 1,3,4-oxadiazolone et médicament - Google Patents

Composé de 1,3,4-oxadiazolone et médicament

Info

Publication number
MA54243A
MA54243A MA054243A MA54243A MA54243A MA 54243 A MA54243 A MA 54243A MA 054243 A MA054243 A MA 054243A MA 54243 A MA54243 A MA 54243A MA 54243 A MA54243 A MA 54243A
Authority
MA
Morocco
Prior art keywords
drug
oxadiazolone compound
oxadiazolone
compound
Prior art date
Application number
MA054243A
Other languages
English (en)
Inventor
Yoshinari Haruta
Hirotaka KAMITANI
Takeo Kikuchi
Hisaaki ZAIMOKU
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of MA54243A publication Critical patent/MA54243A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245—Oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
MA054243A 2018-11-15 2019-11-14 Composé de 1,3,4-oxadiazolone et médicament MA54243A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2018214950 2018-11-15

Publications (1)

Publication Number Publication Date
MA54243A true MA54243A (fr) 2021-09-22

Family

ID=70731909

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054243A MA54243A (fr) 2018-11-15 2019-11-14 Composé de 1,3,4-oxadiazolone et médicament

Country Status (22)

Country Link
US (1) US20220024921A1 (fr)
EP (1) EP3882239A4 (fr)
JP (1) JP7434172B2 (fr)
KR (1) KR20210091767A (fr)
CN (1) CN113302184B (fr)
AU (1) AU2019381493B2 (fr)
BR (1) BR112021009198A2 (fr)
CA (1) CA3117550A1 (fr)
CL (1) CL2021001275A1 (fr)
CO (1) CO2021007442A2 (fr)
EA (1) EA202191349A1 (fr)
EC (1) ECSP21034281A (fr)
IL (1) IL282999A (fr)
MA (1) MA54243A (fr)
MX (1) MX2021005566A (fr)
PE (1) PE20211283A1 (fr)
PH (1) PH12021551103A1 (fr)
SA (1) SA521421997B1 (fr)
SG (1) SG11202104371XA (fr)
TW (1) TWI840448B (fr)
UA (1) UA129949C2 (fr)
WO (1) WO2020100959A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119421876A (zh) 2022-04-25 2025-02-11 日本新药株式会社 作为ddr1激酶抑制剂的化合物和药物
CN117285459B (zh) * 2023-11-24 2024-02-27 上海美迪西生物医药股份有限公司 一种小分子激酶抑制剂化合物的制备方法
CN118515653B (zh) * 2024-07-23 2024-12-10 西湖制药(杭州)有限公司 一种ezh2特异性抑制剂及其制备方法和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01139581A (ja) * 1987-08-20 1989-06-01 Nissan Chem Ind Ltd テトラヒドロフタルイミド誘導体、その製法および除草剤
TW200526626A (en) * 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
WO2006035303A1 (fr) 2004-09-29 2006-04-06 Ranbaxy Laboratories Limited Antagonistes de recepteurs muscariniques
CN101084191A (zh) 2004-12-22 2007-12-05 默克公司 用于制备取代哌啶类化合物的方法
CN102036561A (zh) * 2008-02-29 2011-04-27 赛林药物股份有限公司 蛋白激酶调节剂
GB0813740D0 (en) 2008-07-28 2008-09-03 Angeletti P Ist Richerche Biologica Therapeutic compounds
TWI496779B (zh) 2008-08-19 2015-08-21 Array Biopharma Inc 作為ｐｉｍ激酶抑制劑之三唑吡啶化合物
US9090593B2 (en) * 2010-12-09 2015-07-28 Amgen Inc. Bicyclic compounds as Pim inhibitors
CA2830780A1 (fr) * 2011-03-22 2012-09-27 Amgen Inc. Composes d'azole utilises en tant qu'inhibiteurs des pim
WO2013007765A1 (fr) 2011-07-13 2013-01-17 F. Hoffmann-La Roche Ag Composés tricycliques fusionnés utilisés en tant qu'inhibiteurs des janus kinases
EP2858994A1 (fr) 2012-06-07 2015-04-15 F. Hoffmann-La Roche AG Inhibiteurs de tankyrase à base de pyrazolopyrimidone et de pyrazolopyridone
GB201814151D0 (en) * 2018-08-31 2018-10-17 Ucl Business Plc Compounds

Also Published As

Publication number Publication date
TW202031649A (zh) 2020-09-01
TWI840448B (zh) 2024-05-01
AU2019381493B2 (en) 2024-10-31
AU2019381493A1 (en) 2021-06-03
EP3882239A1 (fr) 2021-09-22
IL282999A (en) 2021-06-30
UA129949C2 (uk) 2025-09-24
SG11202104371XA (en) 2021-05-28
PE20211283A1 (es) 2021-07-19
WO2020100959A1 (fr) 2020-05-22
MX2021005566A (es) 2021-07-15
CO2021007442A2 (es) 2021-06-21
EA202191349A1 (ru) 2021-08-10
PH12021551103A1 (en) 2021-11-22
KR20210091767A (ko) 2021-07-22
CN113302184B (zh) 2024-11-22
CL2021001275A1 (es) 2021-11-05
CA3117550A1 (fr) 2020-05-22
JPWO2020100959A1 (ja) 2021-10-07
BR112021009198A2 (pt) 2021-08-03
CN113302184A (zh) 2021-08-24
EP3882239A4 (fr) 2022-08-10
ECSP21034281A (es) 2021-06-30
JP7434172B2 (ja) 2024-02-20
SA521421997B1 (ar) 2025-04-10
US20220024921A1 (en) 2022-01-27

Similar Documents

Publication Publication Date Title
IL283197A (en) Microbiocidal 2-acylamino-thiazole-4-carboxamide derivatives
IL272089B1 (en) Compounds, compositions and methods
DK4151637T3 (da) Gadolinium-indeholdende pcta-baserede kontrastmidler
EP3816154A4 (fr) Composé hétérocyclique et son application
EP3689892A4 (fr) Médicament radioactif
EP3312162A4 (fr) Composé de diarylazole et pesticide
EP3805223A4 (fr) Dérivé de 2,3-dihydro-1h-pyrrolizine-7-formamide et son application
DK3653613T3 (da) 1,3-disubstitueret ketenforbindelse og anvendelse deraf
EP3415502A4 (fr) Composé hétéroaryle substitué, composition le contenant et application associée
EP3789383A4 (fr) Composé de benzisoxazole
EP3654982A4 (fr) Composés de 1,8-naphthyridinone et leurs utilisations
CL2018003233S1 (es) Bata médica.
EP3808747A4 (fr) Composé d'imidazopyridinone
IL282157A (en) Compounds and therapeutic uses thereof
IL282999A (en) 1,3,4-oxadiazolone compound and pharmaceutical
FR3086177B1 (fr) Autoinjecteur.
EP3760616A4 (fr) Composé de 4-méthyldihydropyrimidinone et son utilisation médicinale
EP3815635A4 (fr) Cathéter
DE112020002320A5 (de) Schmerzmedikament
EP3984534A4 (fr) Composé de diarylamide et son application
EP3485921A4 (fr) Composé empêchant l'adhésion.
DK3770162T3 (da) Dihydrochromenderivater
EP3646865A4 (fr) Médicament
EP3744380A4 (fr) Cathéter
EP3590513A4 (fr) Médicament